Cancer gene therapy, a promising frontier in oncology, targets the genetic abnormalities underlying cancer. This approach involves introducing genetic material into cancerous cells to inhibit their growth or trigger cell death. One strategy employs viral vectors to deliver therapeutic genes selectively to tumor cells, while sparing healthy tissue. Another method utilizes gene editing tools like CRISPR to precisely alter cancer-related genes, correcting mutations or deactivating oncogenes. While still in its infancy, gene therapy holds immense potential for personalized cancer treatment, offering hope for more effective and targeted therapies with fewer side effects. However, challenges such as off-target effects and immune responses remain hurdles to overcome in realizing the full potential of this innovative approach.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States